A single dose of intravenous (IV) iron dextran is the cost-effective treatment for women with heavy menstrual bleeding and ...

Iron deficiency is common in hemodialysis patients for several reasons. These include substantial losses of blood caused by taking frequent blood samples for analysis, blood remaining in the dialysis ...

Credit: Getty Images. The recall was initiated due to product stability testing results that did not meet specifications for iron content. Allergan has expanded its December 2017 voluntary recall of ...

A single dose of intravenous (IV) iron dextran is the cost-effective treatment for women with heavy menstrual bleeding and iron deficiency anemia ...

Intravenous (IV) iron use overall is associated with a “very low” risk for anaphylaxis, but iron dextran and ferumoxytol carry an increased risk relative to iron sucrose, according to new research.

During a period of rapid fluctuation in the intravenous iron market, there was increased use of a more expensive drug that afforded providers additional revenue. Objectives: Medicare Part B payment ...

THE development of sarcomas in rats after the repeated administration of massive doses of iron-dextran complex has been reported by Richmond 1 and confirmed by Haddow and Horning. 2 The latter were ...

Intravenous iron dextran is widely used in hemodialysis patients receiving erythropoietin (EPO) therapy because of its significant convenience in clinical practice. However, the amount of iron removed ...